{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:21:06Z","timestamp":1787239266746,"version":"build-2736575974"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1001\/jamadermatol.2018.3465","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T12:41:55Z","timestamp":1541076115000},"page":"1465","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events"],"prefix":"10.1001","volume":"154","author":[{"given":"Dustin H.","family":"Marks","sequence":"first","affiliation":[{"name":"The George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The George Washington University Medical Faculty Associates, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Friedman","sequence":"additional","affiliation":[{"name":"The George Washington University School of Medicine and Health Sciences, Washington, DC"},{"name":"Department of Dermatology, The George Washington University Medical Faculty Associates, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"drv180004r1","first-page":"371","article-title":"Update on taxane development: new analogs and new formulations.","volume":"6","author":"Yared","year":"2012","journal-title":"Drug Des Dev Ther"},{"issue":"5","key":"drv180004r2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1684\/ejd.2016.2833","article-title":"Dermatological adverse events with taxane chemotherapy.","volume":"26","author":"Sibaud","year":"2016","journal-title":"Eur J Dermatol"},{"issue":"5, pt 2","key":"drv180004r3","first-page":"110S","article-title":"Clinical overview of the taxanes.","volume":"17","author":"Goldspiel","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"10","key":"drv180004r4","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00520-007-0232-0","article-title":"Nail changes due to docetaxel\u2013a neglected side effect and nuisance for the patient.","volume":"15","author":"Winther","year":"2007","journal-title":"Support Care Cancer"},{"key":"drv180004r5","article-title":"Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review","author":"Rubio-Gonzalez","journal-title":"Int J Dermatol"},{"issue":"3","key":"drv180004r6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1078155208100450","article-title":"Nail toxicity induced by cancer chemotherapy.","volume":"15","author":"Gilbar","year":"2009","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"drv180004r7","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S1470-2045(14)71133-7","article-title":"Nail toxicities induced by systemic anticancer treatments.","volume":"16","author":"Robert","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"drv180004r8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/bjd.2015.173.issue-3","article-title":"The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis.","volume":"173","author":"Capriotti","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"drv180004r10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1523-5394.2001.96007.x","article-title":"Psychological sequelae and alopecia among women with cancer.","volume":"9","author":"McGarvey","year":"2001","journal-title":"Cancer Pract"},{"issue":"2","key":"drv180004r11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF01262572","article-title":"Changes in self-concept and body image during alopecia induced cancer chemotherapy.","volume":"5","author":"M\u00fcnstedt","year":"1997","journal-title":"Support Care Cancer"},{"issue":"2","key":"drv180004r12","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss.","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"drv180004r13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/bjd.2009.160.issue-4","article-title":"Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer.","volume":"160","author":"Prevezas","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"drv180004r14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","article-title":"Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling.","volume":"171","author":"Mart\u00edn","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"drv180004r15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaad.2010.03.020","article-title":"Permanent chemotherapy-induced alopecia: a review.","volume":"64","author":"Palamaras","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"19","key":"drv180004r16","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","article-title":"Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.","volume":"23","author":"Scott\u00e9","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"drv180004r17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF00192885","article-title":"Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.","volume":"73","author":"Battegay","year":"1995","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"drv180004r18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1016002329546","article-title":"Docetaxel-induced nail changes\u2013a neurogenic mechanism: a case report.","volume":"58","author":"Wasner","year":"2002","journal-title":"J Neurooncol"},{"issue":"7","key":"drv180004r19","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1016\/S1470-2045(15)00019-4","article-title":"Taxane-related nail toxicity.","volume":"16","author":"Schepisi","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"drv180004r20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jaad.2008.05.018","article-title":"Toxic erythema of chemotherapy: a useful clinical term.","volume":"59","author":"Bolognia","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"drv180004r21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3109\/0284186X.2011.636755","article-title":"Hand and foot syndrome associated with docetaxel treatment.","volume":"51","author":"Stravodimou","year":"2012","journal-title":"Acta Oncol"},{"issue":"1","key":"drv180004r22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1078155213475466","article-title":"Docetaxel-associated palmar-plantar erythrodysesthesia: a case report and review of the literature.","volume":"20","author":"Harris","year":"2014","journal-title":"J Oncol Pharm Pract"},{"issue":"16","key":"drv180004r23","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa0707056","article-title":"Weekly paclitaxel in the adjuvant treatment of breast cancer.","volume":"358","author":"Sparano","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"drv180004r24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.coc.0000026486.56886.18","article-title":"Cutaneous hand and foot toxicity associated with cancer chemotherapy.","volume":"26","author":"Childress","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"drv180004r25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ad.2016.11.014","article-title":"Periarticular thenar erythema and onycholysis syndrome: a manifestation of taxane-induced cutaneous toxicity","volume":"108","author":"Rodr\u00edguez-Lomba","year":"2017","journal-title":"Actas Dermosifiliogr"},{"issue":"6","key":"drv180004r27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3109\/00365518509155250","article-title":"Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man.","volume":"45","author":"B\u00fclow","year":"1985","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"drv180004r28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","article-title":"Chemotherapy-induced alopecia.","volume":"28","author":"Tr\u00fceb","year":"2009","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"drv180004r30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/jnci\/djx178","article-title":"Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial.","volume":"110","author":"Hanai","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"drv180004r31","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00520-013-1842-3","article-title":"Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.","volume":"21","author":"Poi","year":"2013","journal-title":"Support Care Cancer"},{"issue":"9","key":"drv180004r33","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00520-013-1804-9","article-title":"Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.","volume":"21","author":"Betticher","year":"2013","journal-title":"Support Care Cancer"},{"issue":"2","key":"drv180004r34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000048253","article-title":"Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia.","volume":"62","author":"Christodoulou","year":"2002","journal-title":"Oncology"},{"issue":"5","key":"drv180004r35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clbc.2015.01.003","article-title":"Efficacy of scalp cooling in preventing chemotherapy-induced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy.","volume":"15","author":"Cigler","year":"2015","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"drv180004r36","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.3747\/co.23.3200","article-title":"Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients.","volume":"23","author":"Fehr","year":"2016","journal-title":"Curr Oncol"},{"issue":"9","key":"drv180004r37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00520-007-0267-2","article-title":"A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia.","volume":"15","author":"Joshi","year":"2007","journal-title":"Support Care Cancer"},{"issue":"6","key":"drv180004r38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0959-8049(00)00012-5","article-title":"Prevention of chemotherapy-induced alopecia using an effective scalp cooling system.","volume":"36","author":"Katsimbri","year":"2000","journal-title":"Eur J Cancer"},{"issue":"6","key":"drv180004r39","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00520-016-3084-7","article-title":"Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.","volume":"24","author":"Komen","year":"2016","journal-title":"Support Care Cancer"},{"issue":"2","key":"drv180004r40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0959-8049(96)00374-7","article-title":"Effectiveness of cold cap in the prevention of docetaxel-induced alopecia.","volume":"33","author":"Lemenager","year":"1997","journal-title":"Eur J Cancer"},{"issue":"2","key":"drv180004r41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1365-2354.2003.00382.x","article-title":"The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.","volume":"12","author":"Macduff","year":"2003","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6","key":"drv180004r42","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial.","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"drv180004r43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00520-003-0451-y","article-title":"Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.","volume":"11","author":"Ridderheim","year":"2003","journal-title":"Support Care Cancer"},{"issue":"6","key":"drv180004r44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2016.21038","article-title":"Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer.","volume":"317","author":"Rugo","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"drv180004r45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000440636","article-title":"The influence of various parameters on the success of sensor-controlled scalp cooling in preventing chemotherapy-induced alopecia.","volume":"38","author":"Schaffrin-Nabe","year":"2015","journal-title":"Oncol Res Treat"},{"issue":"4","key":"drv180004r46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/0284186X.2012.658966","article-title":"Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.","volume":"51","author":"van den Hurk","year":"2012","journal-title":"Acta Oncol"},{"issue":"12","key":"drv180004r47","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00520-012-1465-0","article-title":"Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.","volume":"20","author":"van den Hurk","year":"2012","journal-title":"Support Care Cancer"},{"issue":"1","key":"drv180004r48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/0284186X.2013.794955","article-title":"Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia.","volume":"53","author":"van den Hurk","year":"2014","journal-title":"Acta Oncol"},{"issue":"1","key":"drv180004r49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-017-4506-z","article-title":"Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.","volume":"167","author":"Rice","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"drv180004r51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2018.04.012","article-title":"Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline\/taxane-based chemotherapy.","volume":"40","author":"Vasconcelos","year":"2018","journal-title":"Breast"},{"key":"drv180004r52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.breast.2018.07.006","article-title":"Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.","volume":"41","author":"Chan","year":"2018","journal-title":"Breast"},{"issue":"5","key":"drv180004r53","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejon.2013.02.004","article-title":"Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.","volume":"17","author":"van den Hurk","year":"2013","journal-title":"Eur J Oncol Nurs"},{"issue":"24","key":"drv180004r54","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1158\/0008-5472.SABCS-09-808","article-title":"Phase II clinical study of protection of nail change and skin toxicity by using a frozen glove in Japanese patients with early breast cancer treated by docetaxel and cyclophosphamide (TC)","volume":"69","author":"Hayashi","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"drv180004r55","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1158\/0008-5472.SABCS-4093","article-title":"Multicenter phase II study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity for the breast cancer patients (Kinki Multidisciplinary Breast Oncology Group: KMBOG-0605).","volume":"69","author":"Sakurai","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"drv180004r56","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.","volume":"112","author":"Scott\u00e9","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"drv180004r57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-011-1641-9","article-title":"Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution survey.","volume":"130","author":"Kawaguchi","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"drv180004r58","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10549-017-4268-7","article-title":"A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant\/adjuvant docetaxel chemotherapy.","volume":"164","author":"Kim","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"drv180004r59","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00520-013-2095-x","article-title":"Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial.","volume":"22","author":"McCarthy","year":"2014","journal-title":"Support Care Cancer"},{"issue":"9","key":"drv180004r60","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00520-011-1308-4","article-title":"Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients.","volume":"20","author":"Ishiguro","year":"2012","journal-title":"Support Care Cancer"},{"issue":"3","key":"drv180004r61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejon.2011.06.007","article-title":"Taxane-induced nail changes: predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.","volume":"16","author":"Can","year":"2012","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"drv180004r62","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1684\/ejd.2011.1390","article-title":"Frostbite as a complication of frozen gloves in the prevention of docetaxel-induced onycholysis.","volume":"21","author":"Begon","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"1","key":"drv180004r63","first-page":"18","article-title":"A case report of a cold water bath to prevent docetaxel induced onycolysis.","volume":"2","author":"Ding","year":"2010","journal-title":"Clin Focus Cancer Med"},{"issue":"4","key":"drv180004r66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","article-title":"Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management.","volume":"71","author":"Miller","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"drv180004r68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archdermatol.2007.28","article-title":"Systematic reviews: grading recommendations and evidence quality.","volume":"144","author":"Robinson","year":"2008","journal-title":"Arch Dermatol"},{"issue":"6330","key":"drv180004r69","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1136\/bmj.284.6330.1674","article-title":"Prevention of doxorubicin-induced alopecia by scalp hypothermia: relation to degree of cooling.","volume":"284","author":"Gregory","year":"1982","journal-title":"BMJ (Clin Res Ed)"},{"issue":"3","key":"drv180004r70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2354.2001.00272.x","article-title":"Hair and cancer chemotherapy: consequences and nursing care\u2013a literature study.","volume":"10","author":"Batchelor","year":"2001","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"2","key":"drv180004r71","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10549-016-3799-7","article-title":"Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia.","volume":"157","author":"Belum","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"drv180004r72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","article-title":"Scalp cooling with adjuvant\/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.","volume":"163","author":"Rugo","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"drv180004r73","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10549-009-0342-0","article-title":"Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling.","volume":"118","author":"Lemieux","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"drv180004r74","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1200\/JCO.2016.34.15_suppl.2564","article-title":"Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): efficacy findings from a phase I safety study.","volume":"34","author":"Lacouture","year":"2016","journal-title":"J Clin Oncol"},{"key":"drv180004r9"},{"key":"drv180004r26","first-page":"208","volume-title":"Dermatologic Principles and Practice in Oncology: Conditions of the Skin, Hair and Nails in Cancer Patients","author":"Garbe","year":"2014"},{"key":"drv180004r29","unstructured":"US Food and Drug Administration. FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy [news release]. Silver Springs, MD. Published July 3, 2017. https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm565599.htm. Accessed March 26, 2018."},{"key":"drv180004r32","unstructured":"Oxford Center for Evidence-based Medicine. Levels of evidence. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/. Updated March 2009. Accessed January 26, 2018."},{"key":"drv180004r50","doi-asserted-by":"crossref","unstructured":"KurbacherC, HerzS, KurbacherA, KolbergG. Sensor-controlled scalp cooling for chemotherapy-induced alopecia: safety and effectiveness in primary breast cancer patients exposed to anthracyclines and\/or taxanes in the neoadjuvant or adjuvant setting. J Clin Oncol. 2018;36(15)(suppl):e22196. http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2018.36.15_suppl.e22196. Accessed June 5, 2018.","DOI":"10.1200\/JCO.2018.36.15_suppl.e22196"},{"key":"drv180004r64","unstructured":"MatsumotoK, HinoC, FukudaK, HamamotoM. Prospective study of ice gel pack as less expensive alternative for prevention of skin and nail toxicity in patients with breast cancer receiving docetaxel. Cancer Res. 2009;69(24)(suppl):abstract 1114. http:\/\/cancerres.aacrjournals.org\/content\/69\/24_Supplement\/1114.short. Accessed June 5, 2018."},{"key":"drv180004r65","unstructured":"Tr\u00fcebRM. Chemotherapy-induced hair loss. Skin Therapy Letter. http:\/\/www.skintherapyletter.com\/hair-loss\/chemotherapy-induced\/. Published August 1, 2010. Accessed March 20, 2018."},{"key":"drv180004r67","unstructured":"Memorial Sloan Kettering Cancer Center. Nail changes during treatment with taxane-based chemotherapy. https:\/\/www.mskcc.org\/cancer-care\/patient-education\/nail-changes-during-treatment-taxanes. Updated September 28, 2017. Accessed March 18, 2018."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2711245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T08:17:53Z","timestamp":1605341873000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.3465"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.3465","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}